The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.

Some believe that future studies are still needed to tease out whether there are high-risk subgroups who will benefit.

A true test of durability will take many more years, but if the valve holds up, it’s “potentially a game changer,” say ...

When encountering elderly ACS patients, clinical judgement is important given the risks of bleeding, says Arnold Seto.

The most read stories this past month detailed the passing of Dimitrios Karmpaliotis and news on Evoque and COVID-19.

Labels for the Pfizer and Moderna shots, which already caution about myocarditis and pericarditis, will more strongly stress ...

The findings highlight the importance of having an EP versed in lead management on the heart valve team, one expert says.

The results suggest minimal health status benefits once TR has dropped by three grades, but further research is needed.

Overall age-adjusted mortality rates have fallen, but the poorest parts of the world aren’t sharing in the benefits.

Permanent pacemaker rates were nearly 18% at 30 days but came down as sites gained experience with the new device.

There have been three deaths and no serious injuries tied to a problem affecting detection of the pumps, according to Abiomed ...

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.